X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Pharma with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs WOCKHARDT LTD. - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA WOCKHARDT LTD. GSK PHARMA/
WOCKHARDT LTD.
 
P/E (TTM) x 60.4 18.3 329.7% View Chart
P/BV x 11.8 1.9 634.1% View Chart
Dividend Yield % 2.1 0.0 -  

Financials

 GSK PHARMA   WOCKHARDT LTD.
EQUITY SHARE DATA
    GSK PHARMA
Mar-16
WOCKHARDT LTD.
Mar-16
GSK PHARMA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs3,8502,000 192.5%   
Low Rs2,966706 420.2%   
Sales per share (Unadj.) Rs332.3403.7 82.3%  
Earnings per share (Unadj.) Rs44.329.5 150.3%  
Cash flow per share (Unadj.) Rs47.242.4 111.5%  
Dividends per share (Unadj.) Rs50.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs202.7323.4 62.7%  
Shares outstanding (eoy) m84.70110.51 76.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x10.33.4 306.0%   
Avg P/E ratio x76.945.9 167.6%  
P/CF ratio (eoy) x72.231.9 226.0%  
Price / Book Value ratio x16.84.2 401.8%  
Dividend payout %112.90-   
Avg Mkt Cap Rs m288,643149,509 193.1%   
No. of employees `0004.67.4 62.5%   
Total wages/salary Rs m4,4349,443 47.0%   
Avg. sales/employee Rs Th6,104.56,048.6 100.9%   
Avg. wages/employee Rs Th961.61,280.2 75.1%   
Avg. net profit/employee Rs Th813.7441.5 184.3%   
INCOME DATA
Net Sales Rs m28,14844,614 63.1%  
Other income Rs m1,218970 125.7%   
Total revenues Rs m29,36645,584 64.4%   
Gross profit Rs m4,7745,038 94.7%  
Depreciation Rs m2481,426 17.4%   
Interest Rs m01,012 0.0%   
Profit before tax Rs m5,7443,570 160.9%   
Minority Interest Rs m0-65 0.0%   
Prior Period Items Rs m06 0.0%   
Extraordinary Inc (Exp) Rs m260-   
Tax Rs m2,018255 792.0%   
Profit after tax Rs m3,7523,257 115.2%  
Gross profit margin %17.011.3 150.2%  
Effective tax rate %35.17.1 492.3%   
Net profit margin %13.37.3 182.6%  
BALANCE SHEET DATA
Current assets Rs m21,46239,906 53.8%   
Current liabilities Rs m10,53618,423 57.2%   
Net working cap to sales %38.848.2 80.6%  
Current ratio x2.02.2 94.0%  
Inventory Days Days6890 75.0%  
Debtors Days Days1698 16.7%  
Net fixed assets Rs m4,71735,832 13.2%   
Share capital Rs m847553 153.3%   
"Free" reserves Rs m16,30830,370 53.7%   
Net worth Rs m17,17135,739 48.0%   
Long term debt Rs m1616,542 0.1%   
Total assets Rs m30,62079,522 38.5%  
Interest coverage xNM4.5-  
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.90.6 163.9%   
Return on assets %12.35.4 228.3%  
Return on equity %21.99.1 239.8%  
Return on capital %33.68.7 388.0%  
Exports to sales %011.6 0.1%   
Imports to sales %15.14.5 337.5%   
Exports (fob) Rs m45,177 0.1%   
Imports (cif) Rs m4,2371,990 212.9%   
Fx inflow Rs m5197,589 6.8%   
Fx outflow Rs m8,3202,878 289.0%   
Net fx Rs m-7,8014,711 -165.6%   
CASH FLOW
From Operations Rs m1,386716 193.5%  
From Investments Rs m5,010-8,182 -61.2%  
From Financial Activity Rs m-6,3832,543 -251.1%  
Net Cashflow Rs m12-4,923 -0.2%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 2.3 443.5%  
FIIs % 23.8 7.7 309.1%  
ADR/GDR % 0.0 0.1 -  
Free float % 15.4 15.4 100.0%  
Shareholders   102,036 67,757 150.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   PFIZER  ABBOTT INDIA  PLETHICO PHARMA  WYETH LTD  ELDER PHARMA  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 24, 2017 12:55 PM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - DIVIS LABORATORIES COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS